AI in Drug Discovery Market to Witness Explosive Growth with a CAGR of 29.6% by 2030

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞

The integration of Artificial Intelligence (AI) into drug discovery has revolutionized the pharmaceutical industry, accelerating the process of identifying new drug candidates, optimizing clinical trials, and reducing costs. As the global market for AI in drug discovery continues to expand, advancements in machine learning, deep learning, and big data analytics are paving the way for more efficient drug development. According to a recent report by Maximize Market Research, the AI in drug discovery market is projected to witness significant growth, with a Compound Annual Growth Rate (CAGR) of 29.6% from 2023 to 2030, driven by the growing demand for faster drug development processes, personalized medicine, and technological advancements in healthcare.

𝐆𝐫𝐚𝐛 𝐲𝐨𝐮𝐫 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐧𝐨𝐰: https://www.maximizemarketresearch.com/request-sample/161733/

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

The AI in drug discovery market is expected to reach a value of USD 1.95 Mn billion by 2030, up from USD 0.15 Bn billion in 2023. The market is primarily driven by factors such as the increasing need for efficient drug discovery processes, the rise of chronic diseases, the growing adoption of AI in healthcare, and the collaboration between AI technology companies and pharmaceutical firms. AI technologies are particularly effective in drug repurposing, predictive modeling, and molecular research, leading to breakthroughs in precision medicine and better outcomes for patients.

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲: 𝐀 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐯𝐞 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲

AI-powered solutions are transforming the landscape of drug discovery by providing quicker, more accurate, and cost-effective ways to identify potential drug candidates. AI technologies like machine learning and neural networks analyze vast amounts of data, identifying patterns that would be impossible for humans to discern. As a result, pharmaceutical companies can streamline the discovery process and bring new drugs to market faster, a critical advantage in today's competitive healthcare environment.

𝐄𝐱𝐜𝐢𝐭𝐞𝐝 𝐭𝐨 𝐝𝐢𝐯𝐞 𝐢𝐧? 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐲𝐨𝐮𝐫 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐭𝐨 𝐮𝐧𝐜𝐨𝐯𝐞𝐫 𝐢𝐭𝐬 𝐜𝐨𝐧𝐭𝐞𝐧𝐭𝐬: https://www.maximizemarketresearch.com/request-sample/161733/ 

𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐟𝐨𝐫 𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐢𝐧 𝐊𝐞𝐲 𝐂𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬

The United States remains a global leader in AI innovation, with numerous pharmaceutical giants and tech companies investing heavily in AI for drug discovery. In particular, companies like IBM, Google DeepMind, and Bristol-Myers Squibb are leading the charge. The U.S. is experiencing rapid growth in AI-driven clinical trials, personalized medicine, and drug development platforms. The federal government's support for AI research and development further strengthens the growth trajectory of this sector.

𝑲𝒆𝒚 𝑻𝒓𝒆𝒏𝒅𝒔 𝒊𝒏 𝒕𝒉𝒆 𝑼.𝑺.

The rise of AI platforms like Insilico Medicine and BenevolentAI, which utilize deep learning to predict molecular activity, is accelerating the speed of drug discovery.
Increasing partnerships between biotech firms and AI companies are driving innovation.
The regulatory environment in the U.S., particularly from the FDA, is becoming more favorable to AI solutions in drug discovery, providing a boost to market growth.

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐕𝐢𝐞𝐭𝐧𝐚𝐦

Vietnam, an emerging market in Southeast Asia, is showing substantial interest in AI technologies for drug discovery. Vietnamese pharmaceutical companies are leveraging AI to enhance research capabilities and shorten drug development cycles. Growing investments in AI and healthcare infrastructure, supported by the Vietnamese government, are further propelling this market.

𝑲𝒆𝒚 𝑶𝒑𝒑𝒐𝒓𝒕𝒖𝒏𝒊𝒕𝒊𝒆𝒔 𝒊𝒏 𝑽𝒊𝒆𝒕𝒏𝒂𝒎

AI integration into drug screening, disease diagnostics, and clinical trials are major focus areas.
Collaboration between local universities and tech companies is expected to result in more homegrown AI solutions for drug discovery.

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐓𝐡𝐚𝐢𝐥𝐚𝐧𝐝

In Thailand, the AI in drug discovery market is growing as AI technologies are applied to both local drug development processes and global partnerships. 𝐓𝐡𝐚𝐢 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 and academic institutions are beginning to collaborate with international tech companies to develop AI-powered solutions aimed at optimizing drug research and development.

𝑶𝒑𝒑𝒐𝒓𝒕𝒖𝒏𝒊𝒕𝒊𝒆𝒔 𝒊𝒏 𝑻𝒉𝒂𝒊𝒍𝒂𝒏𝒅

Significant potential for AI-driven drug discovery in tropical diseases and emerging markets.
Government initiatives to support AI innovation in healthcare offer a robust foundation for future growth.

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐉𝐚𝐩𝐚𝐧

Japan, known for its advanced technological infrastructure, is quickly adopting AI technologies in drug discovery. The Japanese government has heavily invested in AI research, especially in the pharmaceutical and healthcare sectors, to combat aging populations and chronic disease prevalence.

𝑲𝒆𝒚 𝑻𝒓𝒆𝒏𝒅𝒔 𝒊𝒏 𝑱𝒂𝒑𝒂𝒏

Partnerships between 𝐅𝐮𝐣𝐢𝐭𝐬𝐮, 𝐇𝐢𝐭𝐚𝐜𝐡𝐢, and leading pharmaceutical companies like 𝐓𝐚𝐤𝐞𝐝𝐚 are fostering AI-driven drug discovery initiatives.
AI-driven drug repurposing and synthetic biology are gaining popularity in Japan, especially for diseases such as cancer and neurodegenerative disorders.

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚

South Korea is seeing rapid growth in AI-driven drug discovery due to its strong presence in both the tech and pharmaceutical sectors. Companies like 𝐒𝐚𝐦𝐬𝐮𝐧𝐠 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜 and 𝐂𝐞𝐥𝐥𝐭𝐫𝐢𝐨𝐧 are investing in AI technologies to streamline drug development processes.

𝑲𝒆𝒚 𝑮𝒓𝒐𝒘𝒕𝒉 𝑫𝒓𝒊𝒗𝒆𝒓𝒔 𝒊𝒏 𝑺𝒐𝒖𝒕𝒉 𝑲𝒐𝒓𝒆𝒂

The government's support for AI research and technological advancement in healthcare is contributing to the market's expansion.
Increased adoption of AI for precision medicine, particularly in the treatment of cancer and metabolic diseases, is boosting market growth.

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞

Singapore has become a global hub for AI research in healthcare, with many startups and established pharmaceutical companies focusing on AI for drug discovery. The country's favorable regulatory environment, combined with advanced data analytics capabilities, makes it an attractive destination for AI-powered drug discovery solutions.

𝑻𝒓𝒆𝒏𝒅𝒔 𝒊𝒏 𝑺𝒊𝒏𝒈𝒂𝒑𝒐𝒓𝒆

The development of AI platforms focused on oncology, genomics, and personalized medicine.
Collaboration between public and private sectors, particularly in AI, is driving innovation.

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞

Europe is witnessing significant consolidation in the AI in drug discovery sector, as tech firms and pharmaceutical companies merge to pool resources and expertise. The European Union's investment in AI technology, combined with a favorable regulatory framework, is driving the growth of AI-based drug discovery solutions.

𝑲𝒆𝒚 𝑫𝒆𝒗𝒆𝒍𝒐𝒑𝒎𝒆𝒏𝒕𝒔 𝒊𝒏 𝑬𝒖𝒓𝒐𝒑𝒆

Major pharmaceutical companies like 𝐍𝐨𝐯𝐚𝐫𝐭𝐢𝐬 and 𝐒𝐚𝐧𝐨𝐟𝐢 are collaborating with AI startups to advance drug discovery efforts.
AI applications in rare diseases and precision medicine are gaining traction, with a particular focus on genetic therapies.

𝐓𝐨 𝐝𝐞𝐥𝐯𝐞 𝐝𝐞𝐞𝐩𝐞𝐫 𝐢𝐧𝐭𝐨 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐤𝐢𝐧𝐝𝐥𝐲 𝐞𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐥𝐢𝐧𝐤: https://www.maximizemarketresearch.com/request-sample/161733/

𝐊𝐞𝐲 𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭

𝐌𝐞𝐫𝐠𝐞𝐫 𝐨𝐟 𝐓𝐞𝐜𝐡 𝐆𝐢𝐚𝐧𝐭𝐬 𝐚𝐧𝐝 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

In 2023, 𝐁𝐞𝐧𝐞𝐯𝐨𝐥𝐞𝐧𝐭𝐀𝐈 merged with 𝐄𝐱𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐚, creating one of the world's largest AI-driven drug discovery platforms. This merger aims to optimize the drug discovery pipeline and speed up the delivery of new drugs to the market. The deal reflects growing consolidation within the AI and pharmaceutical sectors.

𝐀𝐈-𝐏𝐨𝐰𝐞𝐫𝐞𝐝 𝐃𝐫𝐮𝐠 𝐑𝐞𝐩𝐮𝐫𝐩𝐨𝐬𝐢𝐧𝐠 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬

𝐈𝐧𝐬𝐢𝐥𝐢𝐜𝐨 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞, a leader in AI-driven drug discovery, announced the successful AI-based identification of new indications for existing drugs. This breakthrough has the potential to significantly reduce the time and cost of bringing new therapies to market.

𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐰𝐢𝐭𝐡 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐀𝐮𝐭𝐡𝐨𝐫𝐢𝐭𝐢𝐞𝐬

AI firms are increasingly partnering with the 𝐅𝐃𝐀 and the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐀𝐠𝐞𝐧𝐜𝐲 (EMA) to ensure that AI technologies meet regulatory standards for drug discovery, ensuring both innovation and patient safety.

𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:

𝒃𝒚 𝑶𝒇𝒇𝒆𝒓𝒊𝒏𝒈

Software
Services
Hardware

The market for AI in drug discovery is divided into two segments based on offerings: software and hardware services. Over the course of the projected period, software is anticipated to dominate the market. Pharmaceutical businesses may now more effectively analyze large datasets, model molecular interactions, and forecast therapeutic efficacy thanks to AI software platforms. For tasks like virtual screening, biomarker identification, and drug repurposing, these software solutions incorporate cutting-edge technology like deep learning, natural language processing, and predictive analytics. Software is still essential to the AI ecosystem since it drives the fundamental operations of AI in drug development, even though hardware and services also play a role.

𝒃𝒚 𝑻𝒉𝒆𝒓𝒂𝒑𝒆𝒖𝒕𝒊𝒄 𝑨𝒓𝒆𝒂

Oncology
Neurology
Cardiovascular Diseases
Metabolic Diseases
Immunology
Others

The market is divided into several therapeutic areas, including immunology, metabolic diseases, cardiovascular diseases, neurology, and oncology. In 2023, oncology will hold the biggest proportion of the AI drug discovery market. Given its enormous potential to revolutionize cancer treatment, oncology stands out as the most beneficial therapeutic field for AI in drug discovery. Traditional drug development strategies are long and expensive since cancer is one of the most complicated and heterogeneous diseases, with each kind displaying distinct genetic and molecular profiles.

𝐛𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲

Machine Learning
Natural Language Processing
Others

𝒃𝒚 𝑨𝒑𝒑𝒍𝒊𝒄𝒂𝒕𝒊𝒐𝒏

Target Selection and Validation
Drug Screening and Lead Optimization
Clinical Studies
Preclinical studies
Others

The market for AI in drug discovery is divided into several segments based on application, including pharmacology, drug design, drug screening, and drug repurposing. The market is dominated by AI used in drug design and screening.The AI utilized in drug scanning, according to MMR findings, demonstrated that 70% of antimicrobial activity could correctly anticipate the medication's hazardous qualities with a mere 4% error rate.AI is frequently used to identify inhibitory molecules for particular proteins.

𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐫𝐞𝐧𝐝𝐬? 𝐃𝐨𝐧'𝐭 𝐦𝐢𝐬𝐬 𝐭𝐡𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐬𝐮𝐦𝐦𝐚𝐫𝐲 𝐟𝐨𝐫 𝐯𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧: https://www.maximizemarketresearch.com/market-report/ai-in-drug-discovery-market/161733/

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:

1. GNS Healthcare (US)
2. BioSymetrics (US)
3. BPGbio, Inc (US)
4. Atomwise Inc (US)
5. Insitro (US)
6. NVIDIA Corporation (US)
7. IBM Corporation (US)
8. Microsoft Corporation (US)
9. Aria Pharmaceuticals, Inc. (US)
10. Insilico Medicine (US)
11. NuMedii, Inc. (US)
12. Owkin Inc. (US)
13. Schrödinger, Inc. (US)
14. DEEP GENOMICS (Canada)
15. Cyclica (Canada)
16. BenevolentAI (UK)
17. Exscientia (UK)
18. Iktos (France)
19. Euretos (Netherlands)
20. Evaxion Biotech A/S (Denmark)
21. XtalPi Inc (China)
22. Standigm (South Korea)

𝐔𝐧𝐜𝐨𝐯𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐓𝐨𝐩𝐢𝐜𝐬:

Hydrogen Energy Transition Market https://www.maximizemarketresearch.com/market-report/hydrogen-energy-transition-market/193911/

Power Grid Market https://www.maximizemarketresearch.com/market-report/power-grid-market/195591/

Marine Battery Market https://www.maximizemarketresearch.com/market-report/marine-battery-market/188834/

Hydraulic Fracturing Market https://www.maximizemarketresearch.com/market-report/global-hydraulic-fracturing-market/11697/

Water Desalination Equipment Market https://www.maximizemarketresearch.com/market-report/water-desalination-equipment-market/74584/

Global Thermoelectric Generators Market https://www.maximizemarketresearch.com/market-report/global-thermoelectric-generators-market/29591/

Global Smart Irrigation Controllers Market https://www.maximizemarketresearch.com/market-report/global-smart-irrigation-controllers-market/111459/

Global Virtual Power Plant Market https://www.maximizemarketresearch.com/market-report/virtual-power-plan-market/14847/

Switchgear Market https://www.maximizemarketresearch.com/market-report/global-switchgear-market/1237/

Rainwater Harvesting Market https://www.maximizemarketresearch.com/market-report/rainwater-harvesting-market/12432/

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.